EMD Chemicals Expands Multi-Analyte Portfolio Via Collaboration with MitoSciences

News   Oct 23, 2009

 
EMD Chemicals Expands Multi-Analyte Portfolio Via Collaboration with MitoSciences
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

Computer Program Helps Find Ways to Repurpose Existing Drugs

News

Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.

READ MORE

Machine Learning: Helping Determine How a Drug Affects the Brain

News

Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published today in Brain.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE